GLP-1 receptor agonists and pancreatic safety concerns in type 2 diabetic patients: data from cardiovascular outcome trials
Crossref DOI link: https://doi.org/10.1007/s12020-020-02223-6
Published Online: 2020-02-26
Published Print: 2020-06
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Cao, Chuqing
Yang, Shuting
Zhou, Zhiguang http://orcid.org/0000-0002-0374-1838
Text and Data Mining valid from 2020-02-26
Version of Record valid from 2020-02-26
Article History
Received: 25 November 2019
Accepted: 9 February 2020
First Online: 26 February 2020
Compliance with ethical standards
:
: The authors declare that they have no conflict of interest.